Drug access delays due to pharmaceutical companies not Health Canada

May 12, 2014, Canadian Medical Association Journal

Access to new prescription drugs in Canada is delayed by pharmaceutical company submissions to Health Canada rather than by a longer approval-processing time, according to an analysis published in CMAJ (Canadian Medical Association Journal).

The submission of to Health Canada is substantially delayed compared with submissions in the United States and the European Union.

"New drugs reached the market much later in Canada than in the US and the EU because of long delays before their submission to Health Canada," write Ali Shajarizadeh and Aidan Hollis, Department of Economics, University of Calgary, Calgary, Alberta. "For drugs that were ultimately approved in Canada and in at least one of the other jurisdictions, the mean delay from first submission in either foreign jurisdiction to submission in Canada was 540 days."

The authors determined that the capacity of pharmaceutical companies to navigate the regulatory process in less-profitable countries such as Canada—smaller companies may lack resources and expertise—and the desire to obtain approval of first-in-class drugs with higher potential sales are the main reasons for timing of submissions.

"We found that corporate capacity and priority status of new drugs are important determinants of submission delays," write the authors.

"We believe that the harmonization of the regulatory processes of the FDA and Health Canada may accelerate drug submissions in Canada," conclude the authors, although they note that the situation can vary for each drug.

Explore further: Canada needs national approach to protect against drug shortages

More information: Paper: www.cmaj.ca/lookup/doi/10.1503/cmaj.130814

Related Stories

Canada needs national approach to protect against drug shortages

August 20, 2012
Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with a mandatory reporting system for drug shortages, argues an editorial in CMAJ (Canadian Medical Association Journal) and CPJ (Canadian ...

Prescription drug expenses in Canada are a health-care barrier

September 16, 2013
High drug expenses in Canada are a substantial barrier for people to access prescription drugs outside of hospital, states an analysis in CMAJ (Canadian Medical Association Journal).

Safe prescribing information for children in Canada often hard to find

June 13, 2011
Accurate, safe prescribing information for children is often unavailable to doctors in Canada because pharmaceutical companies will not disclose information to Health Canada, states an editorial in CMAJ (Canadian Medical ...

In drug-approval race, US FDA ahead of Canada, Europe

May 16, 2012
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters ...

Impact of Canada's Common Drug Review on drug listing

October 24, 2011
The number of drugs covered by public drug plans decreased substantially after Canada's Common Drug Review was introduced in 2003, and new drugs were listed more quickly in several of the smaller provinces, found a study ...

US lawmakers reject Canada drug purchases

October 20, 2011
The US Senate Thursday rejected a measure that would have enabled Americans to buy prescription drugs in Canada in a bid to reduce the costs of their health care.

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.